baber/WOPTO huggingface dataset:
Patent DK-0455607-T3 (DK)
Inventor: PALUMBO GIANFRANCO
IPC: A61F13/53
Filed: 1991-04-23
Granted: 1995-11-20
Abstract: An absorbent element (7) for disposable absorbent articles is made of hydrophilic fibres and includes two regions (13, 14) at its two longitudinal ends, in which a hydrogelling absorbent material is distributed in a mixture with the hydrophilic fibres. When the absorbent element (7) is used as an absorbent pad for disposable diapers, the end regions (13, 14) are placed around the user's waist. <IMAGE>
Patent DK-0494592-T3 (DK)
Inventor: WALTER JAMES FREDERIC
IPC: A01N63/30
Filed: 1992-01-02
Granted: 1997-03-03
Abstract: The present invention provides a process, formulations, and method of using a new biopesticide which comprises a prilled formulation comprising a carrier and pathogenic fungal mycelium. <IMAGE>
Patent DK-0522370-T3 (DK)
Inventor: HESS GERHARD
IPC: C08L101/00
Filed: 1992-06-26
Granted: 1998-04-14
Abstract: A plastic moulding composition based on an organic thermoplastic polymer containing a mineral black pigment is suitable as a material for the production of shaped articles which can be provided with characters by the action of laser radiation. The black pigment used is principally animal charcoal, and the thermoplastic polymer is in particular a polyoxymethylene.
Patent DK-0530602-T3 (DK)
Inventor: GODAU CLAUS DI
IPC: C09K23/52
Filed: 1992-08-20
Granted: 2000-08-28
Abstract: A process for the preparation of aqueous epoxy resin dispersions comprising (1) 20 to 75% by weight, based on the total dispersion, of an epoxy resin constituting a condensation product of a) epoxy compounds having at least one epoxy group per molecule and an epoxide equivalent weight of 90 to 3000 g/mol, and b) aromatic polyols; (2) 3 to 20% by weight, based on the total dispersion, of an emulsifier comprising a) a condensation product of an aliphatic polyol and an epoxy compound having at least two epoxy groups per molecule and an epoxide equivalent weight of 90 to 3000 g/mol, the equivalent ratio of the OH groups to the epoxy groups being 1:0.85 to 1:1.5 and the epoxide equivalent weight of this condensation product being between 5000 and 400,000 g/mol, b) an organic solvent, and c) water; (3) up to 10% by weight, based on the total dispersion, of organic solvents; and (4) water in an amount to make up to 100% by weight, which comprises stirring the epoxy resin (1) firstly with the emulsifier (2) and, if appropriate, organic solvents corresponding to (3), and then with water.
Patent DK-0505275-T3 (DK)
Inventor: RONCATO GIORDANO
IPC: D02G3/18
Filed: 1992-03-19
Granted: 1995-03-13
Abstract: Manufacture of a composite yarn made up of continuous glass filaments and of thermoplastic organic material. The process according to the invention consists, starting from a first plant, in drawing organic filaments in the form of one or a number of sheets (33, 34) which converge towards the same point (39), in drawing, starting from a second plant, glass filaments combined into at least one yarn (41), the latter being introduced sideways into the region defined by the organic filaments (40) before being combined with the said filaments at their point of convergence (39). The composite yarn obtained is employed for the production of reinforced articles. <IMAGE>
Patent DK-0514282-T3 (DK)
Inventor: JUNINO ALEX
IPC: A61Q5/00
Filed: 1992-05-15
Granted: 1996-08-12
Abstract: (Alkylamino)mercaptoalkylamides, characterised in that they correspond to the general formula (I) or (II) <IMAGE>  in which:     A represents the divalent radical  -(CH2)n-   n being an integer between 2 and 5, or the divalent radical  -(CH2)2-O-(CH2)2-   m is equal to 0, 1 or 2 R1 represents a hydrogen atom or a linear or branched lower alkyl radical having from 1 to 5 carbon atoms, R2 and R3, which are identical or different, represent a hydrogen atom or a linear or branched lower alkyl radical having from 1 to 4 carbon atoms, it not being possible for R2 and R3 to simultaneously represent a hydrogen atom, the salts of the said compounds of formula (I) as well as their corresponding disulphides, with the exception of the disulphide in which:                      A = -(CH2)2-, m = 0,            R1 and R2 = H, R3 = -C2H5 and X is Cl or Br. Use of the compounds (I) as reducing agents in cosmetic compositions for the permanent deformation of hair.
Patent DK-0605522-T3 (DK)
Inventor: HOOGENBOOM HENDRICUS RENERUS J
IPC: C07K16/00
Filed: 1992-09-23
Granted: 2000-01-17
Abstract: Methods are disclosed which may be used for the production of antibodies, or antibody fragments, which have the same binding specificity as a parent antibody but which have increased human characteristics. Humanised antibodies may be obtained by chain shuffling, perhaps using phage display technology. In one embodiment, a polypeptide comprising a heavy or light chain variable domain of a non-human antibody specific for an antigen of interest is combined with a repertoire of human complementary (light or heavy) chain variable domains. Hybrid pairings which are specific for the antigen of interest are selected. Human chains from the selected pairings may then be combined with a repertoire of human complementary variable domains (heavy or light) and humanised antibody polypeptide dimers can then be selected for binding specificity for antigen. The methods may be combined with CDR-imprinting. In another embodiment, component part of an antigen-binding site of a non-human antibody known to bind a particular antigen is combined with a repertoire of component parts of an antigen-binding site of human antibody, forming a library of antibody polypeptide dimers with antigen-binding sites. Hybrids selected from this library may be used in a second humanising shuffling step, or may already be of sufficient human character to be of value, perhaps after some modification to increase human character still further.
Patent DK-0599153-T3 (DK)
Inventor: BURMESTER I DIPL-CHEM
IPC: G01J5/00
Filed: 1993-11-12
Granted: 1999-08-23
Abstract: The invention relates to a method and a device for the identification of materials. The materials are exposed to laser energy and the heat radiation of the materials is, after heating is complete, measured and evaluated in a manner specific to the material in respect of optical and thermal material properties. At least one point of the surface of the workpieces to be identified is exposed to the laser energy at a point and for a short time. The heat impulse reply of the material characteristic of the surface region exposed is measured in terms of position and time and evaluated in respect of the type of material. <IMAGE>
Patent DK-0616536-T3 (DK)
Inventor: ERKKI I RUOSLAHTI
IPC: A61P17/02
Filed: 1992-12-04
Granted: 1999-10-11
Abstract: The present invention provides a method for treating or arresting the progress of pathologies characterized by an accumulation of extracellular matrix components by providing an agent to suppress the activity of transforming growth factor  beta  (TGF- beta ) a peptide growth factor which is anabolic and leads to fibrosis and angiogenesis. Pathologies which can be so treated include the various fibrotic diseases such as fibrotic cancer, fibrosis of the lungs, arteriosclerosis, post myocardial infarction, cardiac fibrosis, post-angioplasty restenosis, renal interstitial fibrosis, scarring and diabetic nephropathy. The present invention further provides methods for treating diabetes and pharmaceutical compositions useful in such methods.
Patent DK-0677114-T3 (DK)
Inventor: COCHRAN MARK D
IPC: C12N15/863
Filed: 1993-01-13
Granted: 2003-04-22
Abstract: The present invention relates to a recombinant swinepox virus capable of replication comprising foreign DNA inserted into a site in the swinepox viral DNA which is not essential for replication of the swinepox virus. The invention further relates to homology vectors which produce recombinant swinepox viruses by inserting foreign DNA into swinepox viral DNA.
Patent DK-0587858-T3 (DK)
Inventor: CASTENSSON STAFFAN
IPC: A61K9/00
Filed: 1993-04-01
Granted: 2000-12-18
Abstract: PCT No. PCT/SE93/00281 Sec. 371 Date Dec. 20, 1993 Sec. 102(e) Date Dec. 20, 1993 PCT Filed Apr. 1, 1993 PCT Pub. No. WO93/19776 PCT Pub. Date Oct. 14, 1993The invention relates to injectable formulations of growth hormone comprising citrate as buffer substance. The formulation could be an aqueous solution of growth hormone and citrate as buffer substance in a concentration of 2-50 mM. The formulation of the growth hormone could comprise growth factor, amino acids such as e.g. glycine and alanine and/or mannitol or other sugar alcohols and/or glycerol and/or other carbohydrates and optionally a preservative such as benzyl alcohol. The invention also relates to a process for preparation of the formulation by mixing growth hormone with citrate as buffer substance or by adding the constituents of the final formulation on the last gel purification step.
Patent DK-0606459-T3 (DK)
Inventor: STEYN RICARDO
IPC: A61M5/00
Filed: 1993-07-30
Granted: 2001-08-13
Abstract: PCT No. PCT/GB93/01615 Sec. 371 Date Jul. 5, 1994 Sec. 102(e) Date Jul. 5, 1994 PCT Filed Jul. 30, 1993 PCT Pub. No. WO94/03224 PCT Pub. Date Feb. 17, 1994A needle protective device has a tubular member (14) with an end cap (16). One end (12) of the member (10) engages on needle hub (22), and the other end has a cap (16) with an opening (34). The tubular member is flexible and has cut-outs (18) in its wall. Normally the needle (26) is directed away from the opening 34) so that the needle tip is enclosed by the cap (16). To use the needle, the end cap (16) is displaced to bring the needle alongside guide ribs (38) and the tubular member (14) compressed axially to expose the needle (26) through the opening (34).
Patent DK-0662000-T3 (DK)
Inventor: LECLERC CLAUDE
IPC: A61K47/48
Filed: 1993-09-13
Granted: 2000-11-13
Abstract: PCT No. PCT/FR93/00876 Sec. 371 Date Apr. 28, 1995 Sec. 102(e) Date Apr. 28, 1995 PCT Filed Sep. 13, 1993 PCT Pub. No. WO94/06472 PCT Pub. Date Mar. 31, 1994The invention concerns the use, in the induction of an immune response, of a synthetic microparticle polymer carrying on the surface one or more covalently bonded proteins capable of carrying one or more epitopes, the densities of the protein(s) on the surface of the microparticles, and their molecular weights, being adjusted so as to direct the immune response to the induction of a humoral and cellular response or to the induction of a largely cellular response. Said microparticles have an average diameter of approximately 0.25 to 1.5  mu m.
Patent DK-0674084-T3 (DK)
Inventor: PHILIPPI GERD
IPC: E06B3/58
Filed: 1994-06-28
Granted: 2002-02-18
Abstract: The frame has a fixture strip (8) which on the side facing the pane secures with a hook profile (22) under a counter hook profile (30) of the frame. Between the pane and the fixture strip is inserted an elastic sealing profile (10) exerting traction on the hooking on the side turned away from the pane. The sealing profile is pressed against a counter bearing (21) on the frame and furthermore is pressed in the vertical direction to the pane against a second counter bearing (20) on the frame. The two counter bearings are so displaced in relation to the counter hook profile that the fixture strip in its final angle position is insertable vertically to the pane with its hook profile behind the counter hook profile.
Patent DK-0611032-T3 (DK)
Inventor: BERTA NORBERT I
IPC: A61J3/06
Filed: 1994-01-11
Granted: 1998-07-27
Abstract: An apparatus for dipping tablets (10) into gelatin coating material and for spreading and setting the coating immediately after dipping is provided. Carrier plates (50) having a plurality of tablet holders (30) are transported from a tablet loading station to a dipping station along a transport guide. At the dipping station, a carrier plate is mounted to a vacuum chamber (60). A set of vacuum tubes in the vacuum chamber are extended through the tablet holders to contact and lift the tablets off of the holders and secure the tablets to the tubes. In a preferred embodiment, the vacuum chamber is rotated 180 DEG  and a second carrier plate (50') is mounted onto the housing and a second set of tubes secure the tablets to the plate. The carrier plates are alternately dipped and returned to the guide means where new plates with uncoated tablets replace the plates with coated tablets. Immediately after dipping the carrier plates enter a rotating station where the plate is rotated 360 DEG  and then replaced on the guide means for transportation to further processing stations. Preferably, the rotating station includes a similar vacuum chamber with vacuum tubes that are extended into the holder for securing the tablet during rotation. <IMAGE>
Patent DK-0705184-T3 (DK)
Inventor: SONDEREGGER WILHELM
IPC: B60R22/12
Filed: 1994-06-01
Granted: 1997-11-03
Abstract: PCT No. PCT/EP94/01779 Sec. 371 Date Mar. 13, 1996 Sec. 102(e) Date Mar. 13, 1996 PCT Filed Jun. 1, 1994 PCT Pub. No. WO95/00368 PCT Pub. Date Jan. 5, 1995A device detects whether persons are present on seats, for example of a vehicle. An electric monitoring arrangement with electrodes is associated to each person. The electrodes are provided for sensing the human body, in particular the thorax. Mainly the breathing is processed in an evaluation circuit.
Patent DK-0717603-T3 (DK)
Inventor: BLANC JEAN PIERRE
IPC: A47J31/40
Filed: 1994-09-05
Granted: 1998-07-27
Abstract: PCT No. PCT/FR94/01039 Sec. 371 Date Feb. 21, 1996 Sec. 102(e) Date Feb. 21, 1996 PCT Filed Sep. 5, 1994 PCT Pub. No. WO95/07041 PCT Pub. Date Mar. 16, 1995Packaging of ground coffee in the form of pastille, "dosette" or predosed bag (1) usable in espresso coffee machines, the pastille, the "dosette" or the predosed bag (1) being formed of filter-paper (3) which encloses the ground coffee (4). The ground coffee content (4) placed in the pastille or the like is partially or totally circumscribed at its periphery, by at least one piece (6) of a sufficiently rigid material acting as a frame, so that the pastille or the like (1) has a good mechanical behaviour. Application to the production of coffees.
Patent DK-0788355-T3 (DK)
Inventor: RAU FREIHERR VON NAGELL HELMUT
IPC: A61K31/295
Filed: 1995-05-17
Granted: 2000-03-20
Abstract: The use of intravenously administered iron in the therapy of tumoral diseases and/or infectious diseases is disclosed. It has been discovered that the intravenous administration of iron leads to surprising cures of tumoral diseases, as well as infectious diseases.
Patent DK-0772603-T3 (DK)
Inventor: UNGER LILIANE
IPC: C07D401/12
Filed: 1995-07-14
Granted: 2002-07-15
Abstract: The present invention relates to the use of pyrimidine compounds of the following formula:wherein R1, R2, R3, A, B and Ar have the meanings indicated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
Patent DK-0791604-T3 (DK)
Inventor: TANAKA HIDEYUKI
IPC: C08B31/04
Filed: 1995-10-30
Granted: 2001-10-29
Abstract: The method for producing starch esters using vinyl ester as the esterifying agent; The present invention is characterized in that a vinyl ester where the ester residue has from 2 to 18 carbon atoms is used as the esterifying agent and this is reacted with a starch in a non-aqueous organic solvent in presence of an esterification catalyst. This starch ester composition has a high degree of substitution, high molecular weight, high water proof and biodegradability. This starch ester composition may be shaped into the moldings having much higher mechanical strength and better physical properties.
Patent DK-0751692-T3 (DK)
Inventor: LOEBIG NORBERT
IPC: H04Q11/04
Filed: 1996-06-19
Granted: 2004-11-01
Abstract: The connection method allows a number of subscriber networks with respective interfaces, e.g. in accordance with the V5.2 protocol, to be coupled to a communication system having a coupling field , a central control and a number of peripheral control devices for different subscriber groups.  Signalling information provided by a subscriber group is processed at the associated peripheral control device with transfer to a further peripheral control device, at which it is processed via a connection procedure, to select the required speech channel.
Patent DK-0738692-T3 (DK)
Inventor: DE MERINGO ALAIN
IPC: C03C3/091
Filed: 1995-05-24
Granted: 1998-03-02
Abstract: A biologically degradable glass-fiber composition characterized by the following constituents in percent by weight:SiO<sub>2</sub>45 to 60Al<sub>2</sub>O<sub>3</sub>less than 2CaO + MgO10 to 16Na<sub>2</sub>O + K<sub>2</sub>Omore than 18 to 23B<sub>2</sub>O<sub>3</sub>10 to 18P<sub>2</sub>O<sub>5</sub>0 to 4BaO0 to 1Diverse0 to 2.
Patent DK-0776931-T3 (DK)
Inventor: WICKER MICHAEL DR
IPC: C08K3/32
Filed: 1996-11-20
Granted: 2001-09-24
Abstract: A method for the production of a clear, impact-modified moulding composition with little yellowing tendency, which comprises a matrix based on polymethyl methacrylate and a disperse phase, is carried out in 4 stages, comprising: (a) producing a latex dispersion in water with core/shell structure by multi-stage polymerisation, with a first stage giving a hard core with a glass transition temperature (Tg) > 70 degrees C, then a stage giving a polyacrylate elastomer phase with Tg < 25 degrees C and finally stage(s) giving PMMA with Tg > 70 degrees C; (b) coagulation by heating and shear in a first extruder with addition of part of the matrix in the form of a melt, amounting to 5-90 parts weight of the solids content of the latex dispersion, and removing the water present to a residual content of not more than 10 wt.% with respect to total solids; (c) compounding the rest of the matrix, amounting to more than 90 parts weight of the solids content of the latex dispersion, in a second extruder, so that the water present is removed completely, giving a melt mixture; and (d) extrusion, cooling and isolation. Reducing inorganic phosphorus compound(s) (I) of phosphinic and phosphonic acids and the alkali(ne earth) metal, aluminium and ammonium salts, in which the ammonium ion may have up to four 1-4C alkyl and/or 5-8 C cycloalkyl substituents, is added at the earliest in stage (c). Also claimed are: (i) mouldings made from the composition; (ii) high impact moulding compsn. containing a disperse tough phase based on PMMA, the yellowness index of which remains unchanged after repeated melting; (iii) high impact moulding composition having a haze value < 15% after treatment in hot water at 95 degrees C for 5 minutes; (iv) high impact moulding compsn. having a yellowness index < 1.5, preferably < 1.0 without addition of blue; (v) high impact moulding compsn. having a yellowness index of < 0.5, preferably < 0.3 with addition of blue; (vi) high impact moulding compsn. after 5000 hours xenon weathering test having an increase in the yellowness index of < 0.3; and (vii) high impact moulding compsn. having an increase in haze of < 10% after 5000 hrs. xenon weathering test.
Patent DK-0807178-T3 (DK)
Inventor: ROMAIN FELIX
IPC: C12N15/31
Filed: 1996-01-31
Granted: 2004-10-11
Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28 779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
Patent DK-0819036-T3 (DK)
Inventor: BESTENLEHRER ALEXANDER
IPC: B23K26/06
Filed: 1996-04-09
Granted: 1999-10-25
Abstract: Laser machining process, esp. for polishing and texturing of any 2-D or 3-D surface, whereby the surface to be machined is scanned by means of a 3-D contour measuring unit and the data is stored in a reference coordinate system (actual shape), the laser machining parameters being derived from a comparison of actual and required shape. After machining, the surface is scanned again and, if necessary, machining with new parameters is repeated until the required shape has been attained. Laser machining equipment comprising a 3-D contour measuring unit and a control system for the measuring and laser machining units is also claimed.
Patent DK-0790237-T3 (DK)
Inventor: OGAWA KAZUO
IPC: A61K31/473
Filed: 1996-06-07
Granted: 2002-10-14
Abstract: Bicyclolactam compounds represented by general formula (1) are useful as the active ingredient of medicines having an excellent anxiolytic effect and a high safety with little side effects such as a hypnotic effect, a muscle relaxing effect, a sedative effect, etc. In said formula, R represents oxo or -OR<1> (wherein R<1> represents hydrogen or acyl); A represents one of the following groups (2) and (3); Q represents hydrogen or lower alkyl; l is 1 or 2, m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time; R<2> represents optionally substituted benzoyl.
Patent DK-0970092-T3 (DK)
Inventor: POTTS THOMAS M
IPC: C07F7/04
Filed: 1996-11-14
Granted: 2002-09-02
Abstract: Tetraethoxysilane is purified by passing impure material through a gas chromatographic separating column at a temperature below the boiling point of the pure tetraethoxysilane. Separation of pure material from impurities occurs on the column, and the pure material is thereafter cooled and collected in a receiver. The purified tetraethoxysilane has 99.999999% purity based on metals content.
Patent DK-0823998-T3 (DK)
Inventor: BLORTZ DORIS
IPC: A23L27/27
Filed: 1997-08-01
Granted: 2002-04-02
Abstract: The invention makes available a process for preparing a protein hydrolysate from protein-containing animal products, in which process the animal products are hydrolysed using endopeptidases and exopeptidases. The process is characterized in that smoked, protein-containing animal products are employed as protein-containing animal products. It was found that, by using smoked, protein-containing animal products, a protein hydrolysate can be produced which does not have the bitter flavour which arises during the customary hydrolysis of protein-containing animal products. According to the invention, smoked pork rind is preferably employed for the hydrolysis.
Patent DK-0974056-T3 (DK)
Inventor: BURCHELL ANN
IPC: A61K35/18
Filed: 1998-03-03
Granted: 2005-12-05
Abstract: A method of identifying embryonic or fetal red blood cells in a sample containiing maternal blood cells and embryonic or fetal red blood cells or both, the method comprising determining which cell or cells contain or express an adult liver component. A method of isolating embryonic or fetal red blood cells from a sample containing maternal blood cells and embryonic or fetal red blood cells or both, the method comprising isolating the cells which contain or express an adult liver component. A method of determining a fetal abnormality the method comprising identifying or isolating embryonic or fetal cells according to the above methods and analysing said embryonic or early fetal cells for said abnormality. Use of a means for determining whether a cell contains or expresses an adult liver component for identifying or isolating an embryonic or fetal red blood cell.
Patent DK-0991330-T3 (DK)
Inventor: NATARAJAN BHASKER
IPC: A24B15/16
Filed: 1998-05-29
Granted: 2005-10-17
Abstract: The invention relates to a reconstituted smoking material which comprises a non-polyol aerosol generator, no tobacco, binder (optional) and inorganic filler. A further polyol aerosol generator may also be contained in the smoking material. There is also provided a smoking article containing such material in a conventional arrangement or with a core axially disposed within an annulus.
Patent DK-1003631-T3 (DK)
Inventor: SCHILL JOACHIM
IPC: B26D1/00
Filed: 1998-08-17
Granted: 2001-08-13
Abstract: The invention relates to a device for cutting a piece of meat into several slices having the same thickness and weight, which comprises a loading and pre-pressing unit (1) for accommodating and pressing the piece of meat and a grading unit (2) for determining the thickness and the volume of the slices. The invention is also fitted with a slicing unit (3) arranged between the loading and pre-pressing unit (1) to cut the piece of meat (13) into slices (14) as determined by the grading unit (2).